Efficacy and safety of non-transvenous cardioverter defibrillators in infants and young children.


Journal

Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing
ISSN: 1572-8595
Titre abrégé: J Interv Card Electrophysiol
Pays: Netherlands
ID NLM: 9708966

Informations de publication

Date de publication:
Mar 2019
Historique:
received: 25 06 2018
accepted: 07 09 2018
pubmed: 27 9 2018
medline: 30 6 2019
entrez: 27 9 2018
Statut: ppublish

Résumé

Implantable cardioverter defibrillators (ICD) protect from sudden cardiac death (SCD). In infants and young children, ICD implantation and programming is challenging due to small body size, elevated heart rates, and high physical activity. We report our experience applying a non-transvenous ICD (NT-ICD) system to infants and children < 12 years of age and < 45-kg body weight. Between 07/2004 and 07/2016, NT-ICD had been implanted in 36 patients. Nine out of 36 patients (25%) had NT-ICD implantation for primary and 27/36 (75%) for secondary prevention. Underlying diseases included inherited primary electrical arrhythmogenic diseases (n = 26; 72%), cardiomyopathies (n = 8; 22%), and congenital heart defects (n = 2; 6%). The median (interquartile range) age at implantation was 6 (1.9-8.4) years, and the median body weight was 21.7 (11.2-26.8) kg. Three different NT-ICD implantation techniques had been applied over time: (1) abdominal device/subcutaneous shock coil, (2) abdominal device/pleural shock coil, and (3) subcardiac device/pleural shock coil. During median follow-up of 5.2 (2.7-7.2) years, appropriate ICD discharges were documented in 12 (33.3%) and inappropriate shocks in 4 patients (11.1%). In 12/36 individuals (33.3%), a total of 25 surgical revisions were required due to NT-ICD malfunction. Eighteen out of 25 (72%) surgical revisions were necessary in patients with subcutaneous shock coil/abdominal device position. Surgical revisions (3/25, 12%) were significantly reduced (p < 0.001) after modifying the implantation technique to subcardiac device/pleural shock coil. NT-ICD was safe and effective in infants and young children. Appropriate ICD discharges occurred in a considerable number of patients. After modifying the implantation technique, the need for surgical revision could significantly be decreased.

Sections du résumé

BACKGROUND BACKGROUND
Implantable cardioverter defibrillators (ICD) protect from sudden cardiac death (SCD). In infants and young children, ICD implantation and programming is challenging due to small body size, elevated heart rates, and high physical activity.
PURPOSE OBJECTIVE
We report our experience applying a non-transvenous ICD (NT-ICD) system to infants and children < 12 years of age and < 45-kg body weight.
METHODS METHODS
Between 07/2004 and 07/2016, NT-ICD had been implanted in 36 patients. Nine out of 36 patients (25%) had NT-ICD implantation for primary and 27/36 (75%) for secondary prevention. Underlying diseases included inherited primary electrical arrhythmogenic diseases (n = 26; 72%), cardiomyopathies (n = 8; 22%), and congenital heart defects (n = 2; 6%). The median (interquartile range) age at implantation was 6 (1.9-8.4) years, and the median body weight was 21.7 (11.2-26.8) kg. Three different NT-ICD implantation techniques had been applied over time: (1) abdominal device/subcutaneous shock coil, (2) abdominal device/pleural shock coil, and (3) subcardiac device/pleural shock coil.
RESULTS RESULTS
During median follow-up of 5.2 (2.7-7.2) years, appropriate ICD discharges were documented in 12 (33.3%) and inappropriate shocks in 4 patients (11.1%). In 12/36 individuals (33.3%), a total of 25 surgical revisions were required due to NT-ICD malfunction. Eighteen out of 25 (72%) surgical revisions were necessary in patients with subcutaneous shock coil/abdominal device position. Surgical revisions (3/25, 12%) were significantly reduced (p < 0.001) after modifying the implantation technique to subcardiac device/pleural shock coil.
CONCLUSIONS CONCLUSIONS
NT-ICD was safe and effective in infants and young children. Appropriate ICD discharges occurred in a considerable number of patients. After modifying the implantation technique, the need for surgical revision could significantly be decreased.

Identifiants

pubmed: 30255451
doi: 10.1007/s10840-018-0451-y
pii: 10.1007/s10840-018-0451-y
doi:

Types de publication

Comparative Study Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

151-159

Références

Pacing Clin Electrophysiol. 2004 Jul;27(7):924-32
pubmed: 15271011
J Cardiovasc Electrophysiol. 2005 Jan;16(1):69-73
pubmed: 15673391
Z Kardiol. 2005 Jun;94(6):415-8
pubmed: 15940443
J Cardiovasc Electrophysiol. 2006 Jan;17(1):41-6
pubmed: 16426398
J Cardiovasc Electrophysiol. 2006 Jul;17(7):754-9
pubmed: 16836673
Pacing Clin Electrophysiol. 2006 Dec;29(12):1319-25
pubmed: 17201837
Ann Thorac Surg. 2007 Jul;84(1):303-5
pubmed: 17588448
Europace. 2008 Oct;10(10):1152-6
pubmed: 18701602
Heart Rhythm. 2010;7(2):193-8
pubmed: 20022820
Circ Arrhythm Electrophysiol. 2010 Oct;3(5):437-44
pubmed: 20729392
Heart Rhythm. 2011 Jan;8(1):23-8
pubmed: 20887811
Heart Rhythm. 2012 Feb;9(2):199-208
pubmed: 21907171
Pediatr Cardiol. 2012 Apr;33(4):569-75
pubmed: 22314365
Eur Heart J. 2012 Jun;33(11):1351-9
pubmed: 22408031
Circ Arrhythm Electrophysiol. 2014 Dec;7(6):1092-100
pubmed: 25287482
Europace. 2015 Nov;17(11):1601-87
pubmed: 26318695
Int J Cardiol. 2016 Jan 15;203:251-8
pubmed: 26519678
Circulation. 2016 Mar 8;133(10):1006-26
pubmed: 26951821
Ann Thorac Surg. 2016 Aug;102(2):615-9
pubmed: 27207391
Heart Rhythm. 2016 Sep;13(9):1905-12
pubmed: 27321244
Pacing Clin Electrophysiol. 2016 Nov;39(11):1225-1239
pubmed: 27620455
Europace. 2018 Sep 1;20(9):1484-1490
pubmed: 29253120
Ann Thorac Surg. 1998 Mar;65(3):775-8
pubmed: 9527212

Auteurs

Matthias J Müller (MJ)

Department of Pediatric Cardiology and Intensive Care, University Medical Center, Georg August University Goettingen, Robert-Koch-Str. 40, 37075, Göttingen, Germany. matthias.mueller@med.uni-goettingen.de.

Jana K Dieks (JK)

Department of Pediatric Cardiology and Intensive Care, University Medical Center, Georg August University Goettingen, Robert-Koch-Str. 40, 37075, Göttingen, Germany.

David Backhoff (D)

Department of Pediatric Cardiology and Intensive Care, University Medical Center, Georg August University Goettingen, Robert-Koch-Str. 40, 37075, Göttingen, Germany.

Heike E Schneider (HE)

Department of Pediatric Cardiology and Intensive Care, University Medical Center, Georg August University Goettingen, Robert-Koch-Str. 40, 37075, Göttingen, Germany.

Wolfgang Ruschewski (W)

Department of Thoracic, Heart, and Cardiovascular Surgery, University Medical Center, Georg August University Goettingen, Robert-Koch-Str. 40, 37075, Göttingen, Germany.

Theodor Tirilomis (T)

Department of Thoracic, Heart, and Cardiovascular Surgery, University Medical Center, Georg August University Goettingen, Robert-Koch-Str. 40, 37075, Göttingen, Germany.

Thomas Paul (T)

Department of Pediatric Cardiology and Intensive Care, University Medical Center, Georg August University Goettingen, Robert-Koch-Str. 40, 37075, Göttingen, Germany.

Ulrich Krause (U)

Department of Pediatric Cardiology and Intensive Care, University Medical Center, Georg August University Goettingen, Robert-Koch-Str. 40, 37075, Göttingen, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH